Stockreport

Maravai LifeSciences Reports Third Quarter 2024 Financial Results

Maravai LifeSciences Holdings, Inc. - Class A common stock  (MRVI) 
PDF Announces Agreement to Acquire the DNA and RNA business of Officinae Bio, Advancing Support for Innovative Nucleic Acid R&D SAN DIEGO, Calif., Nov. 07, 2024 (GLOBE NE [Read more]